Pictet Asset Management Holding SA
Position in TSHA — Taysha Gene Therapies, Inc.
CIK 1993888
CAROUGE, V8
Position in TSHA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$18,868,473
+$18,782,122 QoQ
Shares Held
2,770,701
+14242.6% QoQ
Ownership
0.850%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 208 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $3,960,623,527 across 131 Biotechnology names. TSHA ranks #53 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
539,255 | $267,864,136 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,014,894 | $190,069,348 | |
| 3 | ARGX |
Argenx SE
|
198,282 | $183,960,091 | |
| 4 | INSM |
INSMED Inc
|
1,220,353 | $130,114,036 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,596,998 | $126,625,971 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
3,468,340 | $122,744,552 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,448,126 | $107,856,424 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
957,785 | $106,342,868 |
All Filings in TSHA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,868,473 | 2,770,701 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $86,351 | 19,318 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $106,249 | 19,318 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||